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1. Introduction 
This review describes the current state of knowledge 
of the mechanisms by which the initiation of protein 
synthesis is controlled in mammalian cells. We have 
chosen to consider only translational control mecha- 
nisms, which limit the rates at which mRNAs are 
translated by the protein synthetic machinery, rather 
than transcriptional control mechanisms, by which 
the number and types of mRNAs available for transla- 
tion are regulated, as the latter are beyond the scope 
of a short review. 
The most extensively studied mammalian system 
and the one from which most knowledge of trans- 
lational control mechanisms has been obtained is the 
reticulocyte and its corresponding cell-free system, 
the reticulocyte lysate. The first part of this review 
deals with the way in which the’ availability of haem 
regulates the rate of protein synthesis in the reticulo- 
cyte lysate. Other factors which can control protein 
synthesis in this system and the similarities between 
control mechanisms which operate under these 
circumstances and those which operate in haem 
deficiency are also discussed. 
The second half of the review is concerned with 
the mechanisms which control rates of protein syn- 
thesis in mammalian cell types other than the 
reticulocyte, where cellular functions are less 
specialised and where the presence of a nucleus 
implies that translational control mechanisms might 
have a different role in the control of protein syn- 
thesis than in the non-nucleated reticulocyte. The 
similarities and differences between these types of 
systems are considered. 
2. Initiation of protein synthesis in the reticulocyte 
lysate 
Protein synthesis in the reticulocyte lysate is 
closely regulated by the supply of haem, as it is in 
whole reticulocytes [ 1,2]. In the presence of haem 
crude reticulocyte lysates synthesize proteins at 
almost the same rates as the whole cells, but in the 
absence of haem protein synthesis is rapidly shut off 
after a lag period, the length of which depends on the 
temperature of incubation [3,4]. The shut off in pro- 
tein synthesis is associated with polysome breakdown 
and a reduction in the level of [40 S . Met-tRNApef] 
initiation complexes indicating a decline in the rate of 
initiation [5]. It is now well established that the 
effects of haem deficiency in the lysate are due to 
the formation of an inhibitor, known as the haem 
controlled repressor (HCR) or haem-regulated inhibitor 
(HRI) [5-71. In the absence of haem this inhibitor is 
formed by conversion of an inactive proinhibitor to 
an active form [8]. This reaction is initially reversible 
by addition of haem but prolonged absence of the 
latter leads to a transition of the HCR to an irreversible 
form [9,10]. It is with this form of HCR that most 
work has been done. 
The most purified preparations of HCR indicate 
80 000-90 000 mol. wt on SDS-polyacrylamide gels 
[ 111. Undoubtedly the most interesting property of 
this inhibitor is that is has protein kinase activity 
specifically directed towards the smallest subunit of 
eukaryotic initiation factor 2 (eIF-2) [ 11,121. Factor 
eIF-2 binds the initiator Met-tRNAf in a ternary com- 
plex with GTPand is involved in [40 S *Met-tRNAp] 
initiation complex formation [ 13 ,141. It now seems 
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certain that the phosphorylation of eIF-2 by HCR is 
associated with the decline in initiation observed in 
the absence of haem. The effects of HCR can be over- 
come by addition of exogenous eIF-2 to the lysate 
[ 15 ,161, and there is a good correlation between the 
effects of molecules which inhibit eIF-2 phosphoryla- 
tion and their ability to stimulate protein synthesis in 
the haem-deficient lysate [ 11 ,17,18]. Furthermore, 
an antiserum to HCR which eliminates the effects of 
the latter on protein synthesis also stops the phos- 
phorylation of eIF-2 [ 191. However a major problem 
still exists in this otherwise consistent model since, 
contrary to expectations, purified eIF-2 is active in 
highly fractionated cell-free systems whether it is 
phosphorylated or not [ 11,20,2 11. It is likely that, 
in such systems, eIF-2 does not recycle and only acts 
stoichiometrically rather than catalytically [20,22]. 
Thus it was suggested that phosphorylation of eIF-2 
by HCR might allow one round of initiation per 
molecule of eIF-2 present, but would still block the 
ability of this factor to recycle [22]. However, it has 
recently been reported that both phosphorylated and 
unphosphorylated eIF-2 can initiate between three 
and five rounds of protein synthesis per molecule 
when added to a lysate [23]. In addition the same 
laboratory has isolated another factor from reticulo- 
cytes which reverses the effect of HCR on protein 
synthesis in lysates. This factor, called anti-inhibitor, 
is distinct from eIF-2 and has no effect on phos- 
phorylation of eIF-2 by HCR [23]. A similar factor 
has been characterised in [24,25]. In the light of this 
evidence it has been suggested that inactivation of 
eIF-2 in haemdeticient lysates is caused by the revers- 
ible binding of that factor to a component, as yet 
unidentified, which is present in crude lysates, but 
which is lost on purification (both HCR and the anti- 
inhibitor being inactive with purified eIF-2). It is 
possible that phosphorylation of eIF-2 may be a 
requirement for this binding to occur and the role of 
the anti-inhibitor could then be to prevent such a 
reaction by itself binding to eIF-2 [23]. 
Several groups have reported the existence of fac- 
tors which stimulate the activity of eIF-2 in fractionated 
cell-free systems and which enhance or restore the 
sensitivity of initiation complex formation to inhibi- 
tion by HCR. The nature of these factors is summarized 
in table 1. Ochoa’s group have purified a stimulatory 
activity from both Artemia (brine shrimp) and rabbit 
reticulocytes, called eIF-2 stimulatory protein (ESP). 
This enhances [eIF-2 . GTP . Met-tRNAf] and 40 S 
Table 1 
Protein factors associated with eIF-2 which modulate its activity in vitro 
Source Activity Mol. wt Ref. 
ESP 
SF 
eIF-2 stimulator 
(GDPase) 
Rat liver 
CO-eIF-2A Rabbit 
(CO-EIF-1) reticulocytes 
COeIF-2B Rabbit 
(TDF) reticulocytes 
COeIF-2C Rabbit 
(eIF-2B) reticulocytes 
SRF 
Artemia and 
rabbit 
reticulocytes 
Rabbit 
reticulocytes 
Rabbit 
reticulocytes 
Stimulates ternary complex formation 
and 40 S initiation complex formation. 
Effect is abolished by HCR ’ 
Stabilizes ternary complexes. Required 
for HCR catalysed inhibition of 
ternary complex formation 
Stimulates ternary complex and 40 S 
initiation complex formation. Has 
GDPase activity 
Stimulates ternary complex formation. 
Binds to eIF-2. Increases rate of 
Met-tRNAyt binding to 40 S subunits 
Dissociates ternary complexes. Stim- 
ulates AUGdependent binding of Met- 
tRNApt to 40 S subunits 
Relieves Mg*’ inhibition of ternary 
complex formation. Does not relieve 
GDP inhibition of ternary complex 
formation 
Reverses inhibitory effect of HCR on 
ternary complex formation and on pro- 
tein synthesis in reticulocyte lysates 
200 000 
250 ooo- 
300 000 
Above 
200 000 
25 000 and 
200 000 forms 
126,271 
1281 
~291 
130,311 
450 000 1321 
2 
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initiation complex formation [26,27]. The stimulation 
is abolished by HCR and it has been proposed that 
phosphorylation of eIF-2 converts it to a form unable 
to interact with ESP [26,27]. Ranu and London have 
identified an eIF-2 stabilization factor (SF) which has 
similar properties to ESP and is required for HCR 
catalysed inh.ibition$f ternary complex formation 
[28]. A similar activity to ESP has also been isolated 
from crude rat liver eIF-2 preparations [29]. This 
stimulates ternary complex formation and also has a 
GDPase activity which may be important in the con- 
trol of eIF-2 activity. Dasgupta et al. have described 
yet another factor (CO-EIF 1, now called CoeIF 2A) 
from reticulocytes which also stimulates ternary com- 
plex formation [30,31]. In addition, this group have 
isolated other proteins which act at the level of the 
ternary complex [32], one of which (TDI) may be 
identical to HCR [33,34]. Another (eIF-2B) now 
called COeIF 2C, has similar properties to ESP and 
SF [35]. 
It seems possible, therefore, that phosphorylation 
of eIF-2 by HCR prevents interaction of the factor 
with one or more co-factors, necessary for the normal 
functioning of eIF-2. A potential mechanism of action 
of such a co-factor could be the removal from eIF-2 
of GDP, which is formed from GTP during initiation 
and is strongly inhibitory. Alternatively the rephos- 
phorylation of eIF-2 bound GDP to GTP might occur 
so that a new ternary complex could then be formed. 
However, a recent report by Benne et al. [36] has cast 
some doubt on the authenticity of some co-factors which 
seem to stimulate ternary complex formation. This group 
has shown that, in assays measuring ternary complex for- 
mation in vitro, there are substantial osses of eIF-2 due 
to adsorption to the wall of the test tube, particularly 
at low concentrations. Addition of proteins isolated 
from lysates, while appearing to stimulate ternary 
complex formation, in fact only enhances recovery of 
eIF-2 and does not increase the activity of the factor. 
It may well be that some of the factors described 
above act in this way and therefore have little physio- 
logical significance. 
Little is known about the mode of activation of 
HCR in the absence of haem and how the presence of 
haem prevents this. There is thought to be a confor- 
mational change involved in the conversion of pro- 
inhibitor to HCR with overt protein kinase activity 
[37 1. Ochoa’s group have proposed a mechanism for 
this activation based on the idea that the proinhibitor 
may be a substrate for a 3’,5’-cyclic AMP-dependent 
protein kinase [3840]. (The HCR protein kinase 
activity itself is cyclic nucleotide independent .) Most 
of the evidence for Ochoa’s model is quite indirect, 
however. Preparations of partially purified or 
apparently homogeneous protein kinase from bovine 
heart, or the catalytic subunit derived from it, were 
reported to inhibit protein synthesis in the reticulocyte 
lysate [38] and the isolated proinhibitor which is 
inactive in assays of protein synthesis or ternary com- 
plex formation, was rendered inhibitory by pre- 
incubation with the kinase or its catalytic subunit 
in an ATP-stimulated manner [38]. Haemin partially 
inhibited the activity of the cyclic AMP-dependent 
protein kinases from reticulocytes or bovine heart 
and prevented kinase-stimulated conversion of pro- 
inhibitor to HCR [39]. It also inhibited the binding 
of cyclic AMP to the protein kinase or its regulatory 
subunit and itself bound to these proteins [40]. 
Finally, cyclic AMP was claimed to stimulate forma- 
tion of HCR from proinhibitor [39]. While this 
evidence appears to provide good support for Ochoa’s 
model of HCR activation it has not been shown that 
the proinhibitor or HCR is a substrate for phos- 
phorylation by exogenous protein kinase or that 
phosphorylation of any protein by this enzyme 
correlates with inhibition of protein synthesis. How- 
ever, it is known that HCR is itself phosphorylated, 
perhaps autocatalytically, when incubated in vitro 
[ 111. Proof of the model also requires it to be shown 
that inhibition of cyclic AMP-dependent protein 
kinases by haemin indirectly prevents phosphoryla- 
tion of eIF-2. In contradiction to Ochoa’s results, 
recent reports from two other laboratories in fact state 
that neither the reticulocyte cyclic AMP-dependent 
protein kinase nor cyclic AMP itself has any effect on 
protein synthesis in the reticulocyte lysate in the 
presence or absence of haem, and neither affects the 
phosphorylation of eIF-2 [41,42]. These results there- 
fore cast considerable doubt on the validity of Ochoa’s 
model. 
A similar effect on protein synthesis in the reticulo- 
cyte lysate to that seen with haem deficiency is pro- 
duced by the presence of low concentrations of double- 
stranded RNA (dsRNA) [43,44], or of oxidised 
glutathione (GSSG) [45] or on incubation at elevated 
temperatures [46]. As with haem deficiency, inhibition 
of protein synthesis in the first two situations is 
accompanied by activation of cyclic AMP-independent 
protein kinase activity that phosphorylates the small 
subunit of eIF-2 [45,47]. The inhibitory effects on 
3 
Volume 110, number 1 FEBS LETTERS January 1980 
protein synthesis can be overcome by addition of 
exogenous eIF-2 [45,47]. The best characterised 
kinase, apart from HCR, is the dsRNA-activated 
protein kinase (ds1 [47] or DA1 [ 111). This is anti- 
genitally distinct from HCR and is associated with 
the ribosomes rather than the post-ribosomal super- 
natant of lysates [47,48]. The mechanism of activa- 
tion of this kinase appears to involve phosphoryla- 
tion of a 67 000 mol. wt ribosome-associated poly- 
peptide [47]. Paradoxically, high concentrations of 
dsRNA can reverse the inhibition of protein synthesis 
[ 17,491 and also prevent the phosphorylation of the 
67 000 mol. wt protein [ 111. 
dsRNA also activates another mechanism for 
inhibiting protein synthesis in the reticulocyte lysate 
which apparently does not involve protein kinases. 
dsRNA stimulates an enzyme which synthesises a 
series of small oligonucleotides, pppA2’p5’A2’ps’A 
and longer oligomers (abbreviated here as 2-SA), 
from ATP [50]. These molecules in turn activate an 
endonuclease which degrades mRNA [51,52]. The 
relative contributions of the two types of mechanism 
to the inhibition of translation by dsRNA in the 
lysate depend on a number of factors, including the 
nature of the dsRNA, the KC1 concentration and the 
type of mRNA being translated [53]. In general, low 
concentrations of naturally occurring dsRNA activate 
the protein kinase and inhibit initiation in a manner 
which is reversible by exogenous eIF-2 or high concen- 
trations of dsRNA [.53]. Intermediate concentrations 
of dsRNA, particularly synthetic polymers such as 
poly(rI):poly(rC), activate the 2-5A synthetase and 
endonuclease system; once the mRNA has been 
degraded, reversibility by eIF-2 is, of course, impossible 
[53]. Both types of translational control are also 
believed to be of considerable importance in the 
mechanism of action of interferon on protein synthesis 
in other cell types following virus infection. 
3. Other systems controlled at the level of 40 S initia- 
tion complex formation 
Although the regulation of initiation by haem in 
reticulocytes has been the most extensively studied 
system, there is now evidence that protein synthesis 
in other, less specialised cells is also controlled at the 
level of 40 S initiation complex formation. 
Nutrient deprivation in intact Ehrlich ascites 
tumour cells reduces the rate of polypeptide chain 
4 
initiation relative to that in fully fed control cells [54]. 
This is accompanied by a similar decrease in the level 
of [40 S . Met-tRNApef] complexes which can be 
observed both in vivo [55] and in extracts prepared 
from fed and starved cells [.56]. The defect in 40 S 
complex formation can be overcome in extracts from 
amino acid-starved cells by exogenous eIF-2 [56]. 
It seems likely that starvation may activate an HCR- 
like protein kinase activity but this has not yet been 
shown. An inhibitor of 40 S initiation complex forma- 
tion has been isolated from Ehrlich cells [.57] but the 
role of this activity in the reduction of the rate of 
initiation of protein synthesis in nutrient deprivation 
remains to be determined. 
The only hormonally sensitive system in which 
initiation complex formation has been assayed is the 
rat ventral prostate gland, which requires androgens 
for its normal growth and function. Castration of the 
male rat has been reported to decrease the ability of 
an eIF-2-like activity in the postribosomal fraction of 
the prostate to form ternary complexes with Met- 
tRNA, and GTP and to bind these to 40 S ribosomal 
subunits [58,.59]. Whether this is due to the formation 
of a translational inhibitor is not known. 
Resting lymphocytes exhibit a much reduced rate 
of polypeptide chain initiation compared to that 
observed in lymphocytes stimulated to proliferate by 
addition of mitogens [60]. Cell-free extracts from 
unstimulated cells also have a reduced ability to form 
40 S initiation complexes compared to extracts 
prepared from phytohaemagglutinin-stimulated cells 
[61], and this difference can be overcome by addition 
of eIF-2 [62]. In this system, however, as well as 40 S 
initiation complex formation, later stages in the initia- 
tion pathway are known to be involved in the regulation 
of protein synthesis [6 1,621. Lymphocytes also con- 
tain a translational inhibitor which appears to work 
by reducing the number of initiation complexes and 
is present in greater amounts in unstimulated cells 
[63], but whether this activity is responsible for 
inactivation of eIF-2 has yet to be determined. 
The best characterised inhibitor of polypeptide 
chain initiation from nonerythroid cells is that which 
has been isolated from rat liver [64]. Its effect on 
protein synthesis in reticulocyte lysates, its chromato- 
graphic behaviour during isolation and its ability to 
phosphorylate the small subunit of eIF-2 suggest it is 
an HCR-like protein kinase. However, its physiological 
significance and its in vivo regulation are also still 
unknown. 
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Another example of control at the level of 40 S 
initiation complex formation is seen in cells treated 
with interferon. Part of the response to this agent 
involves the induction or activation of a latent protein 
kinase which, in the presence of dsRNA or after virus 
infection, phosphorylates eIF-2 [65,66]. It is not 
known if this enzyme is identical to the protein kinase 
activated by dsRNA in reticulocyte lysates, but it is 
tempting to speculate that the addition of dsRNA to 
reticulocyte cell-free systems mimics the effects of 
virus infection in interferon-treated cells. 
4. Systems controlled at later states of initiation 
Although most of the evidence to date suggests 
that initiation rates are controlled primarily at the 
level of 40 S initiation complex formation, there are 
indications that later stages in the initiation sequence 
may also be involved in regulation in some systems. 
It has been claimed recently that the haem-con- 
trolled repressor in reticulocytes, while reducing the 
level of 40 S initiation complexes, also has an inhibitory 
effect on 80 S initiation complex formation [67]. This 
effect was independent of its effect on 40 S com- 
plexes and was thought to be due to inhibition of 
60 S subunit joining. An accumulation of a 48 S initia- 
tion complex containing a 40 S subunit, mRNA and 
Met-tRNAFet was shown [67]. This finding has been 
contradicted by another group however [35]. Another 
situation where the level of 80 S initiation com- 
plexes is reduced is seen in cell-free extracts from 
unstimulated lymphocytes when compared to the 
level found in extracts from stimulated cells [61]. 
This difference may be overcome by the addition of a 
mixture of initiation factors but whether the effect 
is similar to that claimed for HCR in reticulocyte 
lysates is unclear [62]. A reduction in the level of 80 S 
initiation complexes in the presence of added mRNA 
is also seen in cell-free extracts from Krebs ascites cells 
heated to 45”C, compared to those incubated at 37°C 
[68]. This defect may be overcome by adding back a 
mixture of initiation factors. 
It seems likely that control of the rate of poly- 
peptide chain initiation is a more complex process 
than was once assumed. Modulation of several steps 
in the initiation sequence may be involved at the same 
time and situations are known to occur where several 
different control mechanisms act alongside one 
another to limit the rate of protein synthesis. An 
example of this is found in extracts from cells treated 
with interferon where the addition of dsRNA results 
not only in the activation of the protein kinase which 
phosphorylates the small subunit of eIF-2 [65,66], 
but also in the appearance of endoribonuclease activity 
which degrades mRNA [69,70]. It is likely that these 
two enzymes represent wo distinct pathways for the 
inhibition of protein synthesis in interferon treated 
cell extracts; (their relative importance may depend 
on the conditions in the extract). These enzymes are 
also present in reticulocyte lysates, as mentioned 
earlier, and may therefore be part of a more general 
control mechanism limiting the rate of polypeptide 
synthesis. 
5. Conclusions 
This review has described the principal mechanisms 
by which the rate of polypeptide chain initiation is 
controlled in mammalian cells. Using the reticulocyte 
lysate as a model system it now appears likely that 
the control mechanisms found to operate here are 
also present in other cell types and may be of a more 
general nature than was once assumed. It also seems 
probable that more than one step in the initiation 
pathway is subjected to control in these systems and 
that several different control mechanisms may act 
alongside one another. An example of this is seen 
after interferon treatment and viral infection of cells 
in culture. 
A greater understanding of events occurring during 
the regulation of polypeptide chain initiation in the 
reticulocyte lysate should come when the mechanism 
of inactivation of eIF-2 by HCR-catalysed phosphoryla- 
tion is fully elucidated. While this appears to be 
imminent, any real understanding of the way in which 
haem deficiency activates HCR from the pro-inhibitor 
will require much more work. In nonerythroid cells 
effecters other than haem may also be involved in 
similar activations but almost nothing is yet known 
about the control of translational inhibitors which 
may be the analogues of HCR. Detailed insight into 
the mechanisms of HCR activation would therefore be 
a major advance from which such other information 
might be forthcoming. 
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